Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IMCnyeso |
Trade Name | |
Synonyms | |
Drug Descriptions |
IMCnyeso is a bispecific T-cell receptor based therapy that targets NY-ESO-1 and LAGE-1A and also binds to CD3, potentially resulting in increased immune response against NY-ESO1-expressing and LAGE-1A-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C153130 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMCnyeso | IMCnyeso | 0 | 1 |